CN105168145A - Compound amoxycillin soluble powder and preparation method thereof - Google Patents

Compound amoxycillin soluble powder and preparation method thereof Download PDF

Info

Publication number
CN105168145A
CN105168145A CN201510715067.8A CN201510715067A CN105168145A CN 105168145 A CN105168145 A CN 105168145A CN 201510715067 A CN201510715067 A CN 201510715067A CN 105168145 A CN105168145 A CN 105168145A
Authority
CN
China
Prior art keywords
soluble powder
amoxicillin
polyethylene glycol
preparation
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510715067.8A
Other languages
Chinese (zh)
Inventor
谯仕彦
郭文江
吴保庆
陈勇
何涛
刘扬科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Linzhou Sinagri Biological Peptides Technology Co Ltd
Original Assignee
Linzhou Sinagri Biological Peptides Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Linzhou Sinagri Biological Peptides Technology Co Ltd filed Critical Linzhou Sinagri Biological Peptides Technology Co Ltd
Priority to CN201510715067.8A priority Critical patent/CN105168145A/en
Publication of CN105168145A publication Critical patent/CN105168145A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses compound amoxycillin soluble powder. The compound amoxycillin soluble powder is prepared from, by mass, 10%-20% of amoxicillin, 2.5%-5% of clavulanate potassium, 10%-40% of polyethylene glycol, 10%-20% of mannitol and the balance anhydrous glucose. A preparation method of the compound amoxycillin soluble powder comprises the steps that 1, the amoxicillin and the polyethylene glycol are weighed; 2, the weighed materials are evenly mixed and put in a stainless steel drying tray, fusing is conducted in a thermal cycling type drying oven at the temperature ranging from 60 DEG C to 80 DEG C, and the materials are stirred and taken out after being fused; 3, fusant is rapidly cooled and collected, the collected coagulum is smashed through an ultra-low temperature pulverizer and screened through a 80-mesh sieve, and a solid dispersion is obtained; 4, the solid dispersion, the clavulanate potassium and the mannitol are mixed through a three-dimensional motion mixer, and then the anhydrous glucose is mixed with the obtained mixture in an equivalent incremental mode for 20-30 min. The product prepared through the preparation method has the advantages of being good in water solubility, good in fluidity, small in water content, not prone to moisture absorption and the like, and the quality standard of the compound amoxycillin soluble powder is much higher than that of pharmacopeia.

Description

A kind of compound amoxicillin soluble powder and preparation method thereof
Technical field
The present invention relates to a kind of compound amoxicillin soluble powder and preparation method thereof, belong to veterinary drug preparing technical field.
Background technology
Amoxicillin is bacteriogenic natural beta-lactam antibiotic, and containing beta-lactam nucleus in structure, antibacterial action is very weak, but has strong effect wide-spectrum Inhibitory activity.It is combined with beta-lactam antibiotic amoxicillin, makes enzyme level combination formulations, can protect amoxicillin in varying degrees not by beta-lactam enzyme-deactivating, thus improves the effect of the anti-product enzyme fastbacteria of the latter, improves clinical efficacy.Bactericidal action mechanism in amoxicillin is similar with other beta-lactam antibiotic, and namely main penicillin-binding protein (PBPs) combines with antibacterial, affects bacteria cell wall and synthesizes, and bacterial cell swelling is broken and dead.The antibacterial of amoxicillin/clavulanate potassium to resistance to amoxicillin shows and sensitive organism equally valid, all has good antibacterial action to gram positive bacteria and gram-negative bacteria.To alone amoxicillin, the invalid or unconspicuous Kleb of curative effect, resistant Staphylococcus species comprise low-level MRSA, Branhamella, gonococcus etc. and infect and also have certain curative effect this product.
Clavulanate potassium has and very strong draws moist, and stability extreme difference, easy variable color, caking, content decline.From Tablet and Capsula agent, stability is slightly good, and people with there being some superiority, but is not well suited for concerning veterinary drug.After mixing with amoxicillin in addition, water solublity is not fine, can not meet the market demand.So water solublity and the stability of amoxicillin powder will be improved, to break through from prescription and production technology these two aspects.
Summary of the invention
The object of this invention is to provide that a kind of dissolubility is good, the compound amoxicillin soluble powder of good effect, the not easily moisture absorption and preparation method thereof.
Object of the present invention can be achieved through the following technical solutions: a kind of compound amoxicillin soluble powder, it is prepared from by the raw material of following mass percentage: amoxicillin 10-20%, clavulanate potassium 2.5-5%, Polyethylene Glycol 10-40%, mannitol 10-20%, and surplus is anhydrous glucose.
Described Polyethylene Glycol is solid at normal temperatures, is one or more in Macrogol 4000, polyethylene glycol 6000, PEG 8000.
A preparation method for compound amoxicillin soluble powder, comprises the following steps:
1. according to amoxicillin: Polyethylene Glycol=1:1-1:4 takes amoxicillin and Polyethylene Glycol; 2. load weighted mixing of materials is even, put into rustless steel drip pan, carry out melting with heat-circulation type baking oven, temperature controls at 60-80 DEG C, stirs during material melting, takes out; 3. fused mass is cooled rapidly, collect, adopt super-low temperature pulverizator to pulverize the coagulum of collection, cross 80 mesh sieves, obtain solid dispersion; 4. adopt three-dimensional motion mixer solid dispersion, clavulanate potassium and mannitol to be mixed, then taked by anhydrous glucose the mode of equal increments to mix with said mixture, incorporation time is 20-30min.
Step 3. middle fused mass is collected in rustless steel container.
Step 4. middle anhydrous glucose, mannitol pulverized 80 mesh sieves.
Contained by this product, raw material clavulanate potassium is responsive especially to humiture, strictly should control the humidity of whole production process, and ambient temperature should control below 22 DEG C, and relative humidity should control at about 25%RH.
Preparation method disclosed by the invention obtains product good water solubility, good fluidity, and water content is little, not easily the advantage such as moisture absorption, and its quality standard is far above pharmacopoeial quality standard.
Detailed description of the invention
Embodiment 1
A preparation method for compound amoxicillin soluble powder, comprises the following steps:
1. amoxicillin 10g and polyethylene glycol 6000 40g is taken; 2. load weighted mixing of materials is even, put into rustless steel drip pan, carry out melting with heat-circulation type baking oven, temperature controls, at 60 DEG C, to stir during material melting, takes out; 3. fused mass is cooled rapidly, collect in rustless steel container, adopt super-low temperature pulverizator to pulverize the coagulum of collection, cross 80 mesh sieves, obtain solid dispersion; 4. 80 mesh sieves pulverized by anhydrous glucose, mannitol, take clavulanate potassium 5g, mannitol 10g, 100g is supplied with anhydrous glucose, three-dimensional motion mixer is adopted solid dispersion, clavulanate potassium and mannitol to be mixed, then taked by anhydrous glucose the mode of equal increments to mix with said mixture, incorporation time is 20-30min.
Embodiment 2
A preparation method for compound amoxicillin soluble powder, comprises the following steps:
1. amoxicillin 20g and PEG 8000 20g is taken; 2. load weighted mixing of materials is even, put into rustless steel drip pan, carry out melting with heat-circulation type baking oven, temperature controls, at 80 DEG C, to stir during material melting, takes out; 3. fused mass is cooled rapidly, collect in rustless steel container, adopt super-low temperature pulverizator to pulverize the coagulum of collection, cross 80 mesh sieves, obtain solid dispersion; 4. 80 mesh sieves pulverized by anhydrous glucose, mannitol, take clavulanate potassium 4g, mannitol 15g, 100g is supplied with anhydrous glucose, three-dimensional motion mixer is adopted solid dispersion, clavulanate potassium and mannitol to be mixed, then taked by anhydrous glucose the mode of equal increments to mix with said mixture, incorporation time is 20-30min.
Embodiment 3
A preparation method for compound amoxicillin soluble powder, comprises the following steps:
1. amoxicillin 15g and Macrogol 4000 30g is taken; 2. load weighted mixing of materials is even, put into rustless steel drip pan, carry out melting with heat-circulation type baking oven, temperature controls, at 70 DEG C, to stir during material melting, takes out; 3. fused mass is cooled rapidly, collect in rustless steel container, adopt super-low temperature pulverizator to pulverize the coagulum of collection, cross 80 mesh sieves, obtain solid dispersion; 4. 80 mesh sieves pulverized by anhydrous glucose, mannitol, take clavulanate potassium 2.5g, mannitol 20g, 100g is supplied with anhydrous glucose, three-dimensional motion mixer is adopted solid dispersion, clavulanate potassium and mannitol to be mixed, then taked by anhydrous glucose the mode of equal increments to mix with said mixture, incorporation time is 20-30min.
Embodiment 4-embodiment 14
In embodiment 4 to embodiment 14, variable is as following table, and all the other preparation processes are with embodiment 1.

Claims (5)

1. a compound amoxicillin soluble powder, is characterized in that: it is prepared from by the raw material of following mass percentage: amoxicillin 10-20%, clavulanate potassium 2.5-5%, Polyethylene Glycol 10-40%, mannitol 10-20%, and surplus is anhydrous glucose.
2. a kind of compound amoxicillin soluble powder according to claim 1, is characterized in that: described Polyethylene Glycol is solid at normal temperatures, is one or more in Macrogol 4000, polyethylene glycol 6000, PEG 8000.
3. a kind of preparation method of compound amoxicillin soluble powder according to claim 1 or 2, is characterized in that comprising the following steps:
1. according to amoxicillin: Polyethylene Glycol=1:1-1:4 takes amoxicillin and Polyethylene Glycol; 2. load weighted mixing of materials is even, put into rustless steel drip pan, carry out melting with heat-circulation type baking oven, temperature controls at 60-80 DEG C, stirs during material melting, takes out; 3. fused mass is cooled rapidly, collect, adopt super-low temperature pulverizator to pulverize the coagulum of collection, cross 80 mesh sieves, obtain solid dispersion; 4. adopt three-dimensional motion mixer solid dispersion, clavulanate potassium and mannitol to be mixed, then taked by anhydrous glucose the mode of equal increments to mix with said mixture, incorporation time is 20-30min.
4. the preparation method of a kind of compound amoxicillin soluble powder according to claim 3, is characterized in that: step 3. in fused mass collect in rustless steel container.
5. the preparation method of a kind of compound amoxicillin soluble powder according to claim 3, is characterized in that: step 4. in anhydrous glucose, mannitol pulverized 80 mesh sieves.
CN201510715067.8A 2015-10-29 2015-10-29 Compound amoxycillin soluble powder and preparation method thereof Pending CN105168145A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510715067.8A CN105168145A (en) 2015-10-29 2015-10-29 Compound amoxycillin soluble powder and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510715067.8A CN105168145A (en) 2015-10-29 2015-10-29 Compound amoxycillin soluble powder and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105168145A true CN105168145A (en) 2015-12-23

Family

ID=54890924

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510715067.8A Pending CN105168145A (en) 2015-10-29 2015-10-29 Compound amoxycillin soluble powder and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105168145A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105919941A (en) * 2016-05-17 2016-09-07 湖南泰谷生物兽药有限公司 Composition containing amoxicillin and potassium clavulanate, and preparation method thereof
CN108670956A (en) * 2018-07-04 2018-10-19 河南牧翔动物药业有限公司 A kind of amoxicillin soluble powder and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045667A2 (en) * 1999-12-22 2001-06-28 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Water-soluble powders for oral solution and use thereof
CN101023917A (en) * 2006-02-22 2007-08-29 刘凤鸣 Technology for preparing medicine and relative oral preparations
CN102008445A (en) * 2010-12-10 2011-04-13 青岛康地恩药业有限公司 Amoxicillin soluble powder as well as preparation method and application thereof
CN104188914A (en) * 2014-08-08 2014-12-10 河南牧翔动物药业有限公司 Compound amoxicillin powder and production process thereof
CN104983685A (en) * 2015-06-25 2015-10-21 四川恒通动物制药有限公司 Amoxicillin soluble powder and preparation method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045667A2 (en) * 1999-12-22 2001-06-28 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Water-soluble powders for oral solution and use thereof
CN101023917A (en) * 2006-02-22 2007-08-29 刘凤鸣 Technology for preparing medicine and relative oral preparations
CN102008445A (en) * 2010-12-10 2011-04-13 青岛康地恩药业有限公司 Amoxicillin soluble powder as well as preparation method and application thereof
CN104188914A (en) * 2014-08-08 2014-12-10 河南牧翔动物药业有限公司 Compound amoxicillin powder and production process thereof
CN104983685A (en) * 2015-06-25 2015-10-21 四川恒通动物制药有限公司 Amoxicillin soluble powder and preparation method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105919941A (en) * 2016-05-17 2016-09-07 湖南泰谷生物兽药有限公司 Composition containing amoxicillin and potassium clavulanate, and preparation method thereof
CN108670956A (en) * 2018-07-04 2018-10-19 河南牧翔动物药业有限公司 A kind of amoxicillin soluble powder and preparation method thereof

Similar Documents

Publication Publication Date Title
KR101594790B1 (en) Solid dialysis preparation
CN101896167B (en) Pharmaceutical compositions
CN104490841B (en) A kind of Apixaban tablet and preparation method thereof
CN105168145A (en) Compound amoxycillin soluble powder and preparation method thereof
CN102258531B (en) Medicinal composition containing adenosine cyclophosphate and meglumine and preparation method thereof
CN104473920A (en) Compound preparation for treating II type diabetes mellitus and preparation method of compound preparation
CN101744852B (en) Preparation method of acanthopanax effervescent tablet and products thereof
CN105125570B (en) A kind of pharmaceutical composition containing erythromycin thiocyanate and preparation method thereof
CN102525963B (en) Netilmicin sulfate lyophiled powder injection and preparation method thereof
US6464977B2 (en) Solid preparation for dialysis and process for producing the same
CN105287389A (en) Amoxicillin soluble powder and preparation method thereof
CN105476976A (en) Medicine composition and preparing method and application thereof
CN102228450B (en) Nicergoline capsule and production method thereof
CN103690508A (en) Tablet composition containing pitavastatin calcium and preparation method of tablet
CN102058563B (en) Double-controlled release gliclazide sustained-release capsules and preparation method thereof
CN103417501B (en) Pharmaceutical composition of topiramate
CN104740601B (en) A kind of tire ox bone marrow piece and its production method
CN107875137A (en) A kind of Chinese medicine moistureproof coating agent
CN105193760A (en) High-content glucosamine sulfate tablet and preparation method
JP4385802B2 (en) Method for producing powder dialysis agent
CN104224783A (en) Medicine composition containing repaglinide and metformin and preparation method of medicine composition
CN103505474A (en) Preparation of donkey-hide gelatin effervescent tablet
CN105616379A (en) Stable rivaroxaban capsule pharmaceutical composition
US20110033563A1 (en) Stabilized Senna Extract Gel Formulation and Method of Preparation
CN104173314B (en) Tobramycin enteric coatel tablets

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 456550 Luban Avenue, Linzhou industrial cluster, Henan, Anyang, China, No. 8

Applicant after: Linzhou Zhongnong Ying Tai biological peptide Co. Ltd.

Address before: 456550 Luban Avenue, Linzhou industrial cluster, Henan, Anyang, China, No. 8

Applicant before: LINZHOU SINAGRI BIOLOGICAL PEPTIDES TECHNOLOGY CO., LTD.

COR Change of bibliographic data
RJ01 Rejection of invention patent application after publication

Application publication date: 20151223

RJ01 Rejection of invention patent application after publication